Roche Holding AG (1ROG)
MTA
Real-time Data
07:00 AM
Day's Range
395.0052 wk Range
270.00Overview - 1ROG - Roche Holding AG
Key Statistics
Valuation
Enterprise Value
366.46B
P/E (Trailing)
‪24.54‬
Price / Sales (TTM)
‪5.00‬
Price / Book
‪9.00‬
EV / EBITDA
‪14.29‬
Profitability
Profit Margin
‪19.60%‬
Operating Margin
‪36.20%‬
Return on Assets
‪13.50%‬
Return on Equity
‪38.10%‬
Ownership
Shares Outstanding
796.76M
Float
654.08M
Held by Insiders
‪0.00%‬
Held by Institutions
‪44.00%‬
Price stats
Beta
‪0.34‬
50-Day Avg
‪375.09‬
200-Day Avg
‪361.92‬
Dividends
Payout Ratio
‪63.93%‬
Market Cap - 1ROG - Roche Holding AG
Peers - 1ROG - Roche Holding AG
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on MTA.
- 1ROGMTARoche Holding AG288.26BMarket Cap+29.93%52-week change23.93P/E (Trailing)‪19.60%‬Profit Margin
- 1LLYMTAEli Lilly and Company853.56BMarket Cap+44.62%52-week change42.55P/E (Trailing)‪33.52%‬Profit Margin
- 1JNJMTAJohnson & Johnson428.46BMarket Cap+35.82%52-week change31.56P/E (Trailing)‪21.48%‬Profit Margin
- 1ABBVMTAAbbVie Inc.344.57BMarket Cap+21.59%52-week change75.36P/E (Trailing)‪9.80%‬Profit Margin
- 1MRKXMTAMerck & Co., Inc.240.41BMarket Cap+44.15%52-week change125.16P/E (Trailing)‪4.76%‬Profit Margin
- 1NOVNMTANovartis AG238.75BMarket Cap+22.16%52-week change24.05P/E (Trailing)‪22.50%‬Profit Margin
- 1AMGNMTAAmgen Inc.155.67BMarket Cap+34.30%52-week change27.31P/E (Trailing)‪22.95%‬Profit Margin
Profile Summary - 1ROG - Roche Holding AG
About
Roche Holding AG is a Swiss biopharmaceutical and diagnostics company headquartered in Basel, Switzerland. The company develops, manufactures, and markets innovative medicines and diagnostic solutions worldwide, with a strong focus on oncology therapies derived from its integration with Genentech. Its bestselling…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
